Six-month immune responses to mRNA-1273 vaccine in combination antiretroviral therapy treated late presenter people with HIV according to previous SARS-CoV-2 infection

Immune responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccines in people with HIV (PWH) with a history of late presentation (LP) and their durability have not been fully characterized. DESIGN: In this prospective, longitudinal study, we sought to assess T-cell and hum...

Descripción completa

Detalles Bibliográficos
Autores principales: Augello, Matteo, Bono, Valeria, Rovito, Roberta, Tincati, Camilla, d’Arminio Monforte, Antonella, Marchetti, Giulia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Basic Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10355808/
https://www.ncbi.nlm.nih.gov/pubmed/37199415
http://dx.doi.org/10.1097/QAD.0000000000003585

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10355808/
https://www.ncbi.nlm.nih.gov/pubmed/37199415
http://dx.doi.org/10.1097/QAD.0000000000003585

Ejemplares similares